Up­dat­ed da­ta from a tri­al of John­son & John­son’s ex­per­i­men­tal “pret­zel” showed that more than 80% of blad­der ...

A group of Democratic and Republican senators introduced a bill on Thursday that calls for $275 million toward federal ...

Sarepta Therapeutics’ chief scientist suggested that the FDA was ahead of schedule in reviewing the company’s application to ...

Newly appointed CEO Joe Papa outlined his vision for Emergent BioSolutions, which includes winding down two facilities and ...

Jang-Ho Cha had no interest in leaving his post at Novartis, where he led translational medicine for the pharma giant’s work ...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...

For biosimilars to win, AbbVie has to lose, according to Boehringer Ingelheim. The German drugmaker on Wednesday said that ...

Chroma Medicine laid off an undisclosed number of employees earlier this week, as the privately held startup focuses its ...

The Senate Finance Committee released a bipartisan draft legislation on Friday morning that would give Medicare bonuses to healthcare providers that help fight generic drug shortages. “It is ...

AstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell lymphoma, releasing what it ...

GSK wants to present Blenrep to regulatory bodies sooner. The UK pharma will submit Blenrep in second-line multiple myeloma ...

Bristol Myers Squibb will give back a preclinical cancer drug to Schrödinger, returning the SOS1 inhibitor that was part of a ...